Published in Lab Business Week, September 4th, 2005
Net sales for the quarter ended May 28, 2005 were $32 million, up 15% compared with net sales of $27.7 million for the quarter ended May 29, 2004. Sales growth continued to benefit from the voluntary recall of some liquid barium products by the Mallinckrodt division of Tyco International, Ltd.
The company estimates that between $2.3-2.6 million of sales growth for the quarter was attributable to this recall, with the balance attributable to organic growth of computed tomography (CT) products such as the Smoothie line of oral contrasts and the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.